Sugarloaf Wealth Management LLC lifted its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 131.7% in the 4th ...
Palisade Bio's stock saw a surge in volume, trading at 26.97M shares, far exceeding its 107.68k average, with no news cited for the rise. Phase 1 study shows PALI-2108 is safe at 15mg-150mg doses ...
Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback